Company: MDXG
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001376339-25-000009
Chunk: 46

Company: MIMEDX GROUP, INC.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 46
---
 remain open for exam by taxing jurisdictions. Additional prior years may be open to the extent attributes are being carried forward to an open tax year.

17.    Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities

Selected cash payments, receipts, and non-cash activities are as follows (in thousands):Year Ended December 31, 202420232022Cash paid for interest$2,698 $6,034 $4,569 Income taxes paid (refunded)3,247 (548)181 Cash paid for operating leases1,618 1,635 1,567 Non-cash activities:Conversion of Series B Preferred Stock— 87,870 — Fair value of shares received in settlement of litigation9,300 — — Minimum Profit Share Payments pursuant to TELA APA2,731 — — Issuance of shares pursuant to employee stock purchase plan1,582 1,367 — Purchases of equipment included in accounts payable— 228 417 Financing costs incurred but not paid for Citizens Financing Transaction— 138 — Legal fees associated with the Repurchase of Series B Preferred Stock— 45 — Lease right of use asset and liability5,333 — (37)Contingent consideration payable441 — — 

18.    Commitments and Contingencies

Contractual CommitmentsThe Company has commitments for meeting spaces, generally for hotel and conference spaces for company functions. These commitments generally contain renewal options.

F- 36

The estimated meeting space commitments are as follows (in thousands):Year ending December 31,Meeting Space Commitments2025$237 2026108 Total$345 Litigation and Regulatory MattersIn the ordinary course of business, the Company and its subsidiaries may be a party to pending and threatened legal, regulatory, and governmental actions and proceedings (including those described below). In view of the inherent difficulty of predicting the outcome of such matters, particularly where the plaintiffs or claimants seek very large or indeterminate damages or where the matters present novel legal theories or involve a large number of parties, the Company generally cannot predict what the eventual outcome of the pending matters will be, what the timing of the ultimate resolution of these matters will be, or what the eventual recovery, loss, fines or penalties related to each pending matter may be. In accordance with applicable accounting guidance, the Company accrues a liability when legal matters present loss